financetom
Business
financetom
/
Business
/
SEC 'reopens' probe into Neuralink, Musk's lawyer says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SEC 'reopens' probe into Neuralink, Musk's lawyer says
Dec 12, 2024 10:07 PM

Dec 12 (Reuters) - The U.S. Securities and Exchange

Commission (SEC) this week has reopened an investigation into

Elon Musk's brain-chip startup Neuralink, according to a letter

shared by Musk on Thursday on social media platform X.

The Dec. 12 letter from Musk's lawyer Alex Spiro to outgoing

SEC Chair Gary Gensler also noted that the commission had issued

a settlement demand and that Musk had been given 48 hours to

accept making a monetary payment or face charges on multiple

counts.

The amount demanded was not in the letter.

Musk has long sparred with the SEC and last year four

lawmakers asked the commission to investigate whether Elon Musk

committed securities fraud by allegedly misleading investors

about the safety of a brain implant developed by Neuralink.

How much traction the SEC would gain in any action against

Musk is unclear.

The billionaire entrepreneur who also heads Tesla

and SpaceX is set to gain extraordinary influence after spending

more than a quarter of a billion dollars to help Donald Trump

win November's presidential election. His companies are expected

to be well insulated from regulation and enforcement measures.

Trump has also appointed Musk to a task force that plans a

sweeping overhaul of the U.S. government.

Spiro wrote in the letter that he and Musk would not be

intimidated by the SEC and that they reserved their legal

rights.

The SEC and Neuralink did not immediately respond to Reuters

requests for comment outside regular business hours.

Musk's tussles with the SEC include the regulator's probe

into his $44 billion takeover of Twitter, now X.

A federal judge in November rejected the SEC's request to

sanction Elon Musk after he failed to appear for court-ordered

testimony in relation to the matter.

The commission also sued Musk in 2018 over his Twitter posts

about taking Tesla private. He settled that lawsuit by paying a

$20 million fine, agreeing to let Tesla lawyers review some

posts in advance and stepping down as Tesla's chairman.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HWH International Agrees to Sell 1.3 Million Shares to Alset for $585,000
HWH International Agrees to Sell 1.3 Million Shares to Alset for $585,000
Dec 27, 2024
07:25 AM EST, 12/27/2024 (MT Newswires) -- HWH International ( HWH ) said in a filing Thursday that it has entered into a stock purchase agreement to sell 1.3 million common shares to Alset at $0.45 per share for $585,000. As a result of the transaction, Alset and its subsidiaries will increase their ownership of outstanding HWH common stock to...
Top Premarket Gainers
Top Premarket Gainers
Dec 27, 2024
07:20 AM EST, 12/27/2024 (MT Newswires) -- SES AI (SES) shares soared nearly 70% pre-bell Friday, extending Thursday's rally. Quantum-Si (QSI) shares surged 52%, adding to gains from the previous session. Solid Power ( SLDP ) shares were up 46% following a 30% increase in the previous session. ...
Surf Air Mobility Shares Rise Pre-Bell Following Board Stock Purchases
Surf Air Mobility Shares Rise Pre-Bell Following Board Stock Purchases
Dec 27, 2024
07:16 AM EST, 12/27/2024 (MT Newswires) -- Surf Air Mobility ( SRFM ) share prices were up more than 21% in Friday's premarket activity after the company announced share purchases by the company's chairman and co-founder. The company said its Chairman Carl Albert had purchased 14,500 shares while co-founder and board member Sudhin Shahani purchased 17,237 shares for a total...
Kronos Bio, Genentech to Terminate Research Partnership; Shares Down Pre-Bell
Kronos Bio, Genentech to Terminate Research Partnership; Shares Down Pre-Bell
Dec 27, 2024
07:24 AM EST, 12/27/2024 (MT Newswires) -- Kronos Bio ( KRON ) said in a filing Friday it has agreed to terminate a collaboration and license agreement with Genentech, voiding Kronos' rights to all intellectual property generated under two discovery research programs under the partnership. Kronos said it will transfer to Genentech all small molecule compounds, materials and data generated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved